Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
The FDA has awarded a computational science and bioinformatics contract worth up to $112 million to Engility.
Teva and IBM have formed a three-year, Watson-enabled drug repurposing collaboration
Insmed aims to bring a first-in-market therapy to patients in the U.S. suffering from NTM lung disease caused by MAC, a chronic and debilitating condition.
Ginkgo Bioworks has teamed up with Prospect Bio to incorporate biosensors into its organism design process.
InVentiv Health has started using Veeva Systems’ study start-up application to accelerate trial site activation.
A team of clinical trial tech veterans has raised $5 million to fund development and early marketing of a randomization and trial supply management system.
Organ-on-a-chip player Emulate has added $17 million to its Series B round and landed a deal with Covance.
SoftBank is teaming up with Saudi Arabia’s sovereign wealth fund to invest up to $100 billion in tech companies over the next five years.
PierianDx has bought Tute Genomics to gain the genomics platform it built up over its four years of operation and through the takeover of Knome.
Zymergen has raised $130 million to advance its machine learning-enabled microbe design business.
Y Combinator alum Benchling has raised $7 million to advance its cloud electronic lab notebook and CRISPR design software.